Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
基本信息
- 批准号:10612842
- 负责人:
- 金额:$ 72.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAfrican Green MonkeyAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAnimalsApplied ResearchAreaAutopsyBehavioralBiologicalBiological MarkersBiomedical ResearchBiopsyBlood Chemical AnalysisCardiometabolic DiseaseCaribbean regionCercopithecus tantalusCerebrospinal FluidClinical and Translational Science AwardsCommunicable DiseasesCommunitiesConsultationsDataDedicationsDengue FeverDevelopmentDiabetes MellitusDisciplineEnsureEtiologyEvaluationFatty acid glycerol estersFosteringFundingGeneticGenomeGenomicsGenotypeHealthInfluenzaInfrastructureInvestigationLipidsLongevityMaintenanceMeasurementMedicineMetabolicMetabolic DiseasesMethodologyMothersMultimodal ImagingMuscleNeonatalNeurodegenerative DisordersNeurosciencesObesityPathologyPhenotypePhysiologicalPlasmaPlayPopulationPrimatesResearchResearch PersonnelResourcesRespiratory syncytial virusRoleSamplingSerumServicesSiteSourceStudy modelsSynapsesSystemTechnical ExpertiseTissuesTrainingTranslational ResearchUnited States National Institutes of HealthVaccinesVeterinariansViralanimal resourcebiomedical imagingbiomedical resourcecardiometabolismcareerclinical careclinical phenotypecomparativedata archivedata repositoryforestgene therapygenetic pedigreegenetic resourcehuman diseasehuman modelimage translationimaging capabilitiesimaging programinterestmedical schoolsmeetingsnonhuman primatenoveloutreachpathogenphenotypic dataprecision medicineprogramspsychosocial developmentrepositoryreproductiveresearch facilityscreeningsocial grouptraining opportunitytranslational modeltranslational potentialtranslational studyvaccine developmentvervetβ-amyloid burden
项目摘要
This application is a competing renewal of the "Vervet Research Colony as a Biomedical Resource"
(VRC, P40-OD010965). The VRC is the only NIH-funded biomedical research resource for US-born
vervet/African green monkeys (AGM; Chlorocebus aethiops sabaeus) and has been continuously funded
since 2005. The VRC serves a wide range of local, regional and national investigators by providing
animals, biological samples, data, consultation and training pertaining to the use of vervets/AGMs
as multi-categorical, translational models of human disease. Since the previous renewal, the VRC
has provided resources to over 100 investigators, including over 250 animals and over 1,500
biological samples, as well as data and consultation. The VRC has also provided the necessary
infrastructure and technical expertise enabling the on-site use of over 600 animals across 30
different studies. The VRC has facilitated critical translational research across a wide variety of
disciplines, including: a) the development of the vervet as an emerging nonhuman primate model of
Alzheimer's disease risk with a focus on the assessment of amyloid burden, neurodegenerative
disease biomarkers, and synaptic degeneration; b) investigations into the efficacy and enhancement
of vaccines for infectious diseases such as neonatal influenza, respiratory syncytial virus, and
dengue fever; c) studies focused on the etiology and health consequences of diabetes, metabolic
disease and obesity; d) the development of novel, non-invasive biomedical imaging methodologies;
and e) the expansion of the critical genetic resources available for vervets, including the
sequencing of the vervet genome. The aims of the VRC resource are to: 1) provide the scientific
community with access to animals, biological samples, data and expertise to facilitate the use of
vervets for a wide-range of biomedical research; 2) to provide exceptional training opportunities
for veterinarians and researchers interested in using vervets for translational research, and to
serve as a platform for community and scientific outreach to foster better understanding of the use
of nonhuman primates in biomedical research; and 3) to enhance the resource by engaging in applied
research focused on continuing genetic and phenotypic characterization of vervets across the
lifespan and evaluation of the vervet as a potential translational model in novel research areas.
The VRC is a critical component of the Wake Forest Clinical and Translational Science Award (CTSA),
which provides administrative support and facilitates the utilization of the VRC resource across
the larger CTSA network. The VRC is able to take full advantage of a wide-range of existing
research facilities within the Wake Forest School of Medicine, including multi-modal imaging
capabilities, veterinary and pathology expertise, and genetic and analytic resources.
这项申请是“作为生物医学资源的韦尔韦特研究群体”的竞争性更新
(VRC,P40-OD010965)。VRC是美国出生的NIH资助的唯一生物医学研究资源
Verveet/非洲绿猴(AGM;ChlorOcean bus atheiopsSabaeus),并一直得到资助
自2005年以来。VRC为广泛的地方、区域和国家调查人员提供服务
与使用马鞭草/动植物有关的动物、生物样本、数据、咨询和培训
作为人类疾病的多范畴翻译模型。自上次续期以来,VRC
已经为100多名调查人员提供了资源,包括250多只动物和1500多只
生物样本,以及数据和咨询。VRC还提供了必要的
基础设施和技术专长使30个国家的600多只动物能够在现场使用
不同的研究。VRC促进了广泛范围内的批判性翻译研究
学科,包括:a)将鞭毛虫发展为一种新兴的非人类灵长类动物模型
阿尔茨海默病风险,重点评估淀粉样蛋白负荷、神经退行性变
疾病生物标志物和突触变性;b)疗效和增强的研究
针对新生儿流感、呼吸道合胞病毒等传染病的疫苗,以及
登革热;c)研究重点是糖尿病、代谢疾病的病因和健康后果
疾病和肥胖;d)开发新的非侵入性生物医学成像方法;
和e)扩大可供牡蛎使用的关键遗传资源,包括
马鞭草基因组的测序。VRC资源的目的是:1)提供科学的
社区能够获得动物、生物样本、数据和专门知识,以便利使用
用于广泛的生物医学研究的Vervets;2)提供特殊的培训机会
对于有兴趣使用马鞭草进行翻译研究的兽医和研究人员,以及
作为社区和科学宣传的平台,促进对该用途的更好理解
非人灵长类在生物医学研究中的应用;3)通过从事应用来增强资源
研究的重点是持续的遗传和表型特征,在世界各地
在新的研究领域中作为潜在的翻译模型的寿命和评价。
VRC是维克森林临床和翻译科学奖(CTSA)的重要组成部分,
它提供管理支持并促进VRC资源的利用
更大的CTSA网络。VRC能够充分利用现有的广泛的
维克森林医学院内的研究设施,包括多模式成像
能力、兽医和病理学专业知识以及遗传和分析资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Jorgensen其他文献
Matthew Jorgensen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew Jorgensen', 18)}}的其他基金
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10285192 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群
- 批准号:
10379068 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
9471459 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10119382 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10806701 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10710813 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10153904 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
相似海外基金
AN AFRICAN GREEN MONKEY MODEL OF DENGUE HEMORRHAGIC FEVER
登革出血热非洲绿猴模型
- 批准号:
8358010 - 财政年份:2011
- 资助金额:
$ 72.38万 - 项目类别:
EVALUATION OF RECOMBINANT ATTENUATED RSV VACCINES IN THE AFRICAN GREEN MONKEY
非洲绿猴体内重组 RSV 减毒疫苗的评价
- 批准号:
6939778 - 财政年份:2003
- 资助金额:
$ 72.38万 - 项目类别:
PATHOBIOLOGY OF AFRICAN GREEN MONKEY RETROVIRUSES
非洲绿猴逆转录病毒的病理学
- 批准号:
3142662 - 财政年份:1989
- 资助金额:
$ 72.38万 - 项目类别: